BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31309675)

  • 1. The aspartimide problem persists: Fluorenylmethyloxycarbonyl-solid-phase peptide synthesis (Fmoc-SPPS) chain termination due to formation of N-terminal piperazine-2,5-diones.
    Samson D; Rentsch D; Minuth M; Meier T; Loidl G
    J Pept Sci; 2019 Jul; 25(7):e3193. PubMed ID: 31309675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aspartimide problem in Fmoc-based SPPS. Part I.
    Mergler M; Dick F; Sax B; Weiler P; Vorherr T
    J Pept Sci; 2003 Jan; 9(1):36-46. PubMed ID: 12587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-diazepine-2,5-dione ring formation during solid phase synthesis of peptides containing aspartic acid beta-benzyl ester.
    Süli-Vargha H; Schlosser G; Ilas J
    J Pept Sci; 2007 Nov; 13(11):742-8. PubMed ID: 17853501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aspartimide problem in Fmoc-based SPPS. Part III.
    Mergler M; Dick F
    J Pept Sci; 2005 Oct; 11(10):650-7. PubMed ID: 15849777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides--practical aspects of new trialkylcarbinol based protecting groups.
    Behrendt R; Huber S; White P
    J Pept Sci; 2016 Feb; 22(2):92-7. PubMed ID: 26751703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis.
    Palasek SA; Cox ZJ; Collins JM
    J Pept Sci; 2007 Mar; 13(3):143-8. PubMed ID: 17121420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aspartimide problem in Fmoc-based SPPS. Part II.
    Mergler M; Dick F; Sax B; Stähelin C; Vorherr T
    J Pept Sci; 2003 Aug; 9(8):518-26. PubMed ID: 12952393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Fmoc solid-phase peptide synthesis.
    Behrendt R; White P; Offer J
    J Pept Sci; 2016 Jan; 22(1):4-27. PubMed ID: 26785684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Hydrazide as Protection for Carboxylic Acid: Suppression of Aspartimide Formation during Fmoc Solid-Phase Peptide Synthesis.
    Sato K; Uemura H; Narumi T; Mase N
    Org Lett; 2024 May; 26(21):4497-4501. PubMed ID: 38768369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A backbone amide protecting group for overcoming difficult sequences and suppressing aspartimide formation.
    Abdel-Aal AB; Papageorgiou G; Raz R; Quibell M; Burlina F; Offer J
    J Pept Sci; 2016 May; 22(5):360-7. PubMed ID: 27086749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave-assisted solid-phase peptide synthesis based on the Fmoc protecting group strategy (CEM).
    Vanier GS
    Methods Mol Biol; 2013; 1047():235-49. PubMed ID: 23943491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation.
    Clippingdale AB; Barrow CJ; Wade JD
    J Pept Sci; 2000 May; 6(5):225-34. PubMed ID: 10823491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha- and beta- aspartyl peptide ester formation via aspartimide ring opening.
    Stathopoulos P; Papas S; Kostidis S; Tsikaris V
    J Pept Sci; 2005 Oct; 11(10):658-64. PubMed ID: 15884102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent.
    Tickler AK; Barrow CJ; Wade JD
    J Pept Sci; 2001 Sep; 7(9):488-94. PubMed ID: 11587187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Asp-based lactam cyclic peptides using an amide-bonded diaminodiacid to prevent aspartimide formation.
    Li WJ; Chen JY; Zhu HX; Li YM; Xu Y
    Org Biomol Chem; 2024 May; 22(18):3584-3588. PubMed ID: 38623862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of peptide sequences related to thrombospondin: factors affecting aspartimide by-product formation.
    Cebrián J; Domingo V; Reig F
    J Pept Res; 2003 Dec; 62(6):238-44. PubMed ID: 14632926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.